Can Hair Loss Pills Cause Erectile Dysfunction?

Many men face a difficult choice: treat hair loss or avoid the potential risk of erectile dysfunction (ED, or the inability to get or maintain an erection).
The relationship between hair loss pills and erectile dysfunction is complex, and it’s difficult to say with certainty whether these medications cause sexual problems. “Many affected men have comorbid conditions, like stress, anxiety, or metabolic syndrome, that can independently contribute to erectile dysfunction,” says Justin Houman, MD, a urologist with Tower Urology at Cedars-Sinai in Los Angeles.
Although the research is still ongoing and conflicting, some evidence suggests a potential connection between hair loss pills and sexual issues.
Which Hair Loss Pills Have Been Linked to Erectile Dysfunction?
Not every hair loss pill is linked to ED — and much of the research is still evolving. It’s important to speak to your doctor about what types of hair loss pills may be best for you based on your health history, existing conditions, and concerns.
“As with any long-term therapy, shared decision-making and regular monitoring ensure patients maintain both confidence and safety throughout treatment,” says Dr. Houman.
Finasteride and Erectile Dysfunction
By lowering DHT levels, finasteride may reduce hormone activity in the prostate, penis, and nervous system. “The reduction of these hormone levels can interfere with the body’s ability to make nitric oxide which is important for libido, mood, and erections, explains Houman. “The result can be diminished sexual desire, weaker erections, or delayed orgasm in some men,” he adds.
Other Hair Loss Drugs That Have Not Been Linked to Erectile Dysfunction
For men concerned about sexual side effects, there are other hair loss treatments that may carry lower risk.
The Latest Science on Finasteride and Sexual Health Side Effects
The varying results in studies is likely because researchers looked at different groups of men and different doses, and asked about side effects in different ways, says Houman.
But the research is still limited: Most studies involve a small number of participants, including volunteers who may seek studies because they are having issues, which can skew results, says Houman. Plus, there aren’t objective lab tests to confirm what’s happening biologically yet, he adds.
Is Finasteride Erectile Dysfunction Reversible?
Other Risks and Side Effects for Finasteride and Other Hair Loss Drugs
Oral Finasteride
Topical Finasteride
- Anxiety
- Suicidal thoughts
- Brain fog
- Depression
- Fatigue
- Insomnia
- Testicular pain
Topical Minoxidil
- Changes in hair color or texture
- Dizziness
- Unexpected hair growth
The Takeaway
- The hair loss medication finasteride may cause erectile dysfunction and other sexual side effects, such as low libido and delayed ejaculation.
- Topical finasteride and minoxidil are alternatives that may carry lower sexual health risks than oral finasteride.
- Most sexual side effects resolve within weeks to months are stopping finasteride, though some men report persistent symptoms.
- Talk to your doctor right away if you are taking hair loss pills and notice new or concerning symptoms, including erectile dysfunction, depression, anxiety, or dizziness.
- Finasteride (Oral Route). Mayo Clinic.
- Salisbury BH et al. 5α-Reductase Inhibitors. StatPearls Publishing. June 8, 2024.
- Lee S et al. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-Analysis. Advances in Dermatology and Venereology. September 11, 2018.
- FDA Alerts Health Care Providers, Compounders and Consumers of Potential Risks Associated With Compounded Topical Finasteride Products. U.S. Food and Drug Administration. April 22, 2025.
- Piraccini BM et al. Efficacy and Safety of Topical Finasteride Spray Solution for Male Androgenetic Alopecia: A Phase III, Randomized, Controlled Clinical Trial. Journal of the European Academy of Dermatology and Venereology. October 25, 2021.
- Minoxidil (Topical Route). Mayo Clinic.
- de Fátima Viana Santana Fe et al. Comparative Effects of Finasteride and Minoxidil on the Male Reproductive Organs: A Systematic Review of in Vitro and in Vivo Evidence. Toxicology and Applied Pharmacology. November 1, 2023.
- Oral Minoxidil Offers Strong Results Against Alopecia. Cleveland Clinic. October 13, 2022.
- Minoxidil (Oral Route). Mayo Clinic. January 1, 2026.
- Khera M et al. Penile Vascular Abnormalities in Young Men With Persistent Side Effects After Finasteride Use for the Treatment of Androgenic Alopecia. Translational Andrology and Urology. June 2020.
- Estill MC et al. Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects. Georgetown Medical Review. October 27, 2023.
- Lonergan EM et al. 8679 Case: The Sexual, Physical and Psychological Effects of Post-Finasteride Syndrome. Journal of the Endocrine Society. October 5, 2024.
- Frequently Asked Questions. Post-Finasteride Syndrome Foundation.
- Should I Worry About Finasteride Side Effects Even After Stopping the Drug? Harvard Medical School. September 11, 2021.
- Vasconcelos P et al. Associations Between Sexual Health and Well-Being: A Systematic Review. Bulletin of the World Health Association. November 4, 2024.
- Zito PM et al. Finasteride. StatPearls Publishing. February 28, 2024.
- Lyakhovitsky A et al. The Risk of Psychiatric Disorders in Finasteride Users With Benign Prostatic Hyperplasia and Androgenetic Alopecia: A Population-Based Case-Control Study. Australasian Journal of Dermatology. December 2024.
- Nguyen DD et al. Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride. JAMA Dermatology. November 11, 2020.
- Side Effects of Finasteride. NHS. August 2, 2023.
- Minoxidil Topical Solution or Foam. Cleveland Clinic.

Christopher Wolter, MD
Medical Reviewer
Christopher Wolter, MD, is an assistant professor in urology at Mayo Clinic in Phoenix, Arizona. He has been in practice since 2008, specializing in the areas of urinary incontinence, pelvic organ prolapse, urologic reconstruction, urologic prosthetics, post prostate cancer survivorship, erectile dysfunction, neurourology and neuromodulation, and overall functional considerations of urogenital health.
Dr. Wolter has been heavily involved in urologic education. He spent the last 12 years heavily involved in resident education and leadership for his department, including the last eight years as urology residency program director. He currently serves as the director of urologic education for the preclinical and clinical rotations for the Mayo Clinic Alix School of Medicine Phoenix, Arizona, campus.
Wolter completed his undergraduate and medical education at the University of Illinois. He then completed his urology residency at Tulane University in New Orleans, followed by a fellowship in female pelvic medicine and reconstructive urology at Vanderbilt University in Nashville, Tennessee.

Kelsey Kloss
Author
Kelsey Kloss is a health and wellness journalist with over a decade of experience. She started her career as an in-house editor for brands including Reader’s Digest, Elle Decor, Good Housekeeping, Prevention, Woman's Day, and Redbook, and her work has been featured in over 50 publications.